Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemia-Reference-Cited by-同舟云学术

Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemia

Published:2020-08-28 Issue:1 Volume:25 Page:1-8
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Wada Takashi^ORCID,Hara Akinori,Muso Eri,Maruyama Shoichi,Kato Sawako,Furuichi Kengo,Yoshimura Kenichi,Toyama Tadashi,Sakai Norihiko,Suzuki Hiroyuki,Tsukamoto Tatsuo,Miyazaki Mariko,Sato Eiichi,Abe Masanori,Shibagaki Yugo,Narita Ichiei,Goto Shin,Sakamaki Yuichi,Yokoyama Hitoshi,Mori Noriko,Tanaka Satoshi,Yuzawa Yukio,Hasegawa Midori,Matsubara Takeshi,Wada Jun,Tanabe Katsuyuki,Masutani Kosuke,Abe Yasuhiro,Tsuruya Kazuhiko,Fujimoto Shouichi,Iwatsubo Shuji,Tsuda Akihiro,Suzuki Hitoshi,Kasuno Kenji,Terada Yoshio,Nakata Takeshi,Iino Noriaki,Sofue Tadashi,Miyata Hitomi,Nakano Toshiaki,Ohtake Takayasu,Kobayashi Shuzo,

Funder

Kaneka Inc

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10157-020-01959-9.pdf

Reference17 articles.

1. Kobayashi S. Applications of LDL-apheresis in nephrology. Clin Exp Nephrol. 2008;12:9–15. https://doi.org/10.1007/s10157-007-0003-8.

2. Kobayashi S, Oka M, Moriya H, Maesato K, Okamoto K, Ohtake T. LDL-Apheresis reduces P-selectin, CRP and fibrinogen—possible important implications for improving atherosclerosis. Ther Apher Dial. 2006;10:219–23. https://doi.org/10.1111/j.1744-9987.2006.00332.x.

3. Wada T, Muso E, Maruyama S, et al. Rationale and study design of a clinical trial to assess the effects of LDL apheresis on proteinuria in patients with diabetes and severe proteinuria and dyslipidemia. Clin Exp Nephrol. 2018;22:591–6. https://doi.org/10.1007/s10157-017-1488-4.